After our project review, Ian Piper and I had an interesting discussion which we’d like to get everybody’s views on.
It seemed to us a lot of innovation in health care starts with the wrong people, and ends in the wrong place! Manufacturers of drugs and devices decide which innovations are required, and have to engage the clinical community in the benefits post clinical trials.
How much more appropriate would it be for clinicians to decide the innovations required, and associated benefits, and work with suppliers on the research?
Surely the innovation process would deliver more, with less cost and effort, and achieve more for all stakeholders, if clinicians could drive the process.